Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
Blood|October 25, 2003
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasiaAnna Rogers, Youngson Joe, Taghi Manshouri, et al.European Journal of Haematology|August 22, 2003
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myelomaMaha Ahmed, Francis Giles, Youngson Joe, et al.Cancer|April 4, 2003
Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemiaSherif Ibrahim, Iman Jilani, Susan O'Brien, et al.Leukemia Research|June 27, 2006
Effects of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, on human mast cells bearing wild-type or mutated codon 816 c-kitSrdan Verstovsek, Cem Akin, Taghi Manshouri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosisAlfonso Quintás-Cardama, Hagop M Kantarjian, Taghi Manshouri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosisSrdan Verstovsek, Ayalew Tefferi, Jorge Cortes, et al.Investigational New Drugs|May 27, 2009
MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cellsMirna Golemovic, Alfonso Quintás-Cardama, Taghi Manshouri, et al.Blood|August 17, 2006
EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutationJingxuan Pan, Alfonso Quintás-Cardama, Hagop M Kantarjian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia veraAlfonso Quintás-Cardama, Hagop Kantarjian, Taghi Manshouri, et al.Leukemia Research|May 15, 2002
Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndromeChung Wu Lin, Taghi Manshouri, Iman Jilani, et al.Pageof 9